Clinical characteristics and aetiology of uveitis in a viral haemorrhagic fever zone.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
15 May 2024
Historique:
received: 31 07 2023
accepted: 29 02 2024
revised: 27 01 2024
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 15 5 2024
Statut: aheadofprint

Résumé

Studies on uveitis in Sierra Leone were conducted prior to the Ebola Virus Disease epidemic of 2013-16, which was associated with uveitis in 20% of survivors. They did not include imaging or investigation of tuberculosis and used laboratory services outside the country. We performed a cross-sectional study on patients presenting with uveitis to establish their clinical characteristics and identify the impact of in-country laboratory diagnoses. We invited uveitis cases presenting to Eye Clinics in Sierra Leone from March to September 2022 to participate in the study. They underwent a diagnostic work-up, including fundus and ocular coherence tomography imaging. Active uveitis cases underwent further investigations including serology and immunological tests for syphilis, tuberculosis, herpetic viruses and HIV and chest radiographs. We recruited 128 patients. The median age was 34 (IQR 19) years and there was an equal gender split. Panuveitis was the predominant anatomical uveitis type (n = 51, 40%), followed by posterior uveitis (n = 36, 28%). Bilateral disease affected 40 patients (31%). Active uveitis was identified in 75 (59%) cases. ICD 11 definition of blindness with VA < 3/60 occurred in 55 (33%) uveitis eyes. Aetiology of uveitis from clinical and laboratory assessment demonstrated that most cases were of undifferentiated aetiology (n = 66, 52%), followed by toxoplasmosis (n = 46, 36%). Trauma contributed to eight (6%) cases, syphilis to 5 (4%) cases and Ebola to 2 (2%). Uveitis was associated with high levels of visual impairment. Posterior and panuveitis contributed to the highest proportion of uveitis cases. Laboratory studies helped differentiate syphilis as a significant aetiology of uveitis.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
Studies on uveitis in Sierra Leone were conducted prior to the Ebola Virus Disease epidemic of 2013-16, which was associated with uveitis in 20% of survivors. They did not include imaging or investigation of tuberculosis and used laboratory services outside the country. We performed a cross-sectional study on patients presenting with uveitis to establish their clinical characteristics and identify the impact of in-country laboratory diagnoses.
METHODS METHODS
We invited uveitis cases presenting to Eye Clinics in Sierra Leone from March to September 2022 to participate in the study. They underwent a diagnostic work-up, including fundus and ocular coherence tomography imaging. Active uveitis cases underwent further investigations including serology and immunological tests for syphilis, tuberculosis, herpetic viruses and HIV and chest radiographs.
RESULTS RESULTS
We recruited 128 patients. The median age was 34 (IQR 19) years and there was an equal gender split. Panuveitis was the predominant anatomical uveitis type (n = 51, 40%), followed by posterior uveitis (n = 36, 28%). Bilateral disease affected 40 patients (31%). Active uveitis was identified in 75 (59%) cases. ICD 11 definition of blindness with VA < 3/60 occurred in 55 (33%) uveitis eyes. Aetiology of uveitis from clinical and laboratory assessment demonstrated that most cases were of undifferentiated aetiology (n = 66, 52%), followed by toxoplasmosis (n = 46, 36%). Trauma contributed to eight (6%) cases, syphilis to 5 (4%) cases and Ebola to 2 (2%).
CONCLUSIONS CONCLUSIONS
Uveitis was associated with high levels of visual impairment. Posterior and panuveitis contributed to the highest proportion of uveitis cases. Laboratory studies helped differentiate syphilis as a significant aetiology of uveitis.

Identifiants

pubmed: 38750125
doi: 10.1038/s41433-024-03009-0
pii: 10.1038/s41433-024-03009-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491–500. https://pubmed.ncbi.nlm.nih.gov/15019324/ .
doi: 10.1016/j.ophtha.2003.06.014 pubmed: 15019324
Dandona L, Dandona R, John RK, McCarty CA, Rao GN. Population based assessment of uveitis in an urban population in southern India. Br J Ophthalmol. 2000;84:706–9. https://pubmed.ncbi.nlm.nih.gov/10873978/ .
doi: 10.1136/bjo.84.7.706 pubmed: 10873978 pmcid: 1723526
Jones NP. The Manchester Uveitis Clinic: the first 3000 patients–epidemiology and casemix. Ocul Immunol Inflamm. 2015;23:118–26. https://pubmed.ncbi.nlm.nih.gov/24295124/ .
doi: 10.3109/09273948.2013.855799 pubmed: 24295124
Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer EM, D’Amico DJ, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593–9. https://pubmed.ncbi.nlm.nih.gov/8619771/ .
doi: 10.1001/archopht.1996.01100130585016 pubmed: 8619771
Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943–8. https://pubmed.ncbi.nlm.nih.gov/16282128/ .
doi: 10.1080/02713680500263606 pubmed: 16282128
Pattern of uveitis in a referral eye clinic in north India - PubMed. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/15283216/ .
Ayanru JO. The problem of uveitis in Bendel State of Nigeria: experience in Benin City. Br J Ophthalmol. 1977;61:655–9. https://pubmed.ncbi.nlm.nih.gov/563237/ .
doi: 10.1136/bjo.61.10.655 pubmed: 563237 pmcid: 1043078
Adelowo OO, Akpabio AA, Oderinlo O, Okonkwo ON, Raphael J. Case Series and Literature Review of Ophthalmologic Disorders Seen in a Specialist Rheumatology Clinic in Lagos, Nigeria. Ocul Immunol Inflamm. 2019;27:905–11. https://pubmed.ncbi.nlm.nih.gov/31314623/ .
doi: 10.1080/09273948.2019.1611873 pubmed: 31314623
Ayena KD, Vonor K, Santos M, Sounouvou I, Odoulami-Yehouessi L, Diallo JW, et al. Epidemiological profile of patients with uveitis in Boko and Parakou, in northern Bénin. Med Sante Trop. 2017;27:315–8. https://pubmed.ncbi.nlm.nih.gov/28947410/ .
pubmed: 28947410
Ronday MJH, Stilma JS, Barbe RF, McElroy WJ, Luyendijk L, Kolk AHJ, et al. Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol. 1996;80:956–61. https://pubmed.ncbi.nlm.nih.gov/8976721/ .
doi: 10.1136/bjo.80.11.956 pubmed: 8976721 pmcid: 505671
World Population Dashboard -Sierra Leone | United Nations Population Fund. 2023. Available from: https://www.unfpa.org/data/world-population/SL .
Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol. 2007;125:544–50. https://pubmed.ncbi.nlm.nih.gov/17420375/ .
doi: 10.1001/archopht.125.4.544 pubmed: 17420375
Agua-Agum J, Allegranzi B, Ariyarajah A, Aylward RB, Blake IM, Barboza P, et al. After Ebola in West Africa–Unpredictable Risks, Preventable Epidemics. N Engl J Med. 2016;375:587–96. https://pubmed.ncbi.nlm.nih.gov/27509108/ .
doi: 10.1056/NEJMsr1513109 pubmed: 27509108
MC Sneller, C Reilly, M Badio, RJ Bishop, AO Eghrari, SJ Moses, et al. A Longitudinal Study of Ebola Sequelae in Liberia. N Engl J Med. 2019;380:924–34. Available from: https://pubmed.ncbi.nlm.nih.gov/30855742/ .
Shantha JG, Crozier I, Yeh S. An update on ocular complications of Ebola virus disease. Curr Opin Ophthalmol. 2017;28:600.
doi: 10.1097/ICU.0000000000000426 pubmed: 28872492 pmcid: 5988239
VizHub - GBD Results. 2023. Available from: https://vizhub.healthdata.org/gbd-results/ .
London NJS, Rathinam SR, Cunningham ET. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin. 2010;50:1–17. https://pubmed.ncbi.nlm.nih.gov/20375859/ .
doi: 10.1097/IIO.0b013e3181d2cc6b pubmed: 20375859
Trusko BE, Thorne J, Jabs D, Belfort R, Dick A, Gangaputra S, et al. The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med. 2013;52:259–60. https://pubmed.ncbi.nlm.nih.gov/23392263/ .
doi: 10.3414/ME12-01-0063 pubmed: 23392263 pmcid: 8728398
Jabs DA, Nussenblatt RB, Rosenbaum JT, Atmaca LS, Becker MD, Brezin AP, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16. https://pubmed.ncbi.nlm.nih.gov/16196117/ .
doi: 10.1016/j.ajo.2005.03.057 pubmed: 16196117
Yeh S, Shantha JG, Hayek B, Crozier I, Smith JR. Clinical Manifestations and Pathogenesis of Uveitis in Ebola Virus Disease Survivors. Ocul Immunol Inflamm. 2018;26:1128–34. https://pubmed.ncbi.nlm.nih.gov/29993303/ .
doi: 10.1080/09273948.2018.1484493 pubmed: 29993303
Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med. 2015;372:2423–7. https://pubmed.ncbi.nlm.nih.gov/25950269/ .
doi: 10.1056/NEJMoa1500306 pubmed: 25950269 pmcid: 4547451
Shantha JG, Mattia JG, Goba A, Barnes KG, Ebrahim FK, Kraft CS, et al. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone. EBioMedicine. 2018;30:217–24. https://pubmed.ncbi.nlm.nih.gov/29622497/ .
doi: 10.1016/j.ebiom.2018.03.020 pubmed: 29622497 pmcid: 5952345
Steptoe PJ, Momorie F, Fornah AD, Komba SP, Emsley E, Scott JT, et al. Multimodal Imaging and Spatial Analysis of Ebola Retinal Lesions in 14 Survivors of Ebola Virus Disease. JAMA Ophthalmol. 2018;136:689–93. https://pubmed.ncbi.nlm.nih.gov/29800941/ .
doi: 10.1001/jamaophthalmol.2018.1248 pubmed: 29800941
Steptoe PJ, Scott JT, Baxter JM, Parkes CK, Dwivedi R, Czanner G, et al. Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016 - Volume 23, Number 7—July 2017 - Emerging Infectious Diseases journal - CDC. Emerg Infect Dis. 2017;23:1102–9. https://wwwnc.cdc.gov/eid/article/23/7/16-1608_article .
doi: 10.3201/eid2307.161608 pubmed: 28628441 pmcid: 5512503
Bajwa A, Osmanzada D, Osmanzada S, Khan I, Patrie J, Xin W, et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol. 2015;9:889–901. https://pubmed.ncbi.nlm.nih.gov/26056428/ .
doi: 10.2147/OPTH.S80972 pubmed: 26056428 pmcid: 4445955
Llorenç V, Mesquida M, Sainz De La Maza M, Keller J, Molins B, Espinosa G, et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93:561–7. https://pubmed.ncbi.nlm.nih.gov/25683136/ .
doi: 10.1111/aos.12675 pubmed: 25683136
O’Reilly GM, Cameron PA, Joshipura M. Global trauma registry mapping: a scoping review. Injury. 2012;43:1148–53. https://pubmed.ncbi.nlm.nih.gov/22483995/ .
doi: 10.1016/j.injury.2012.03.003 pubmed: 22483995
Golestani A, Shobeiri P, Sadeghi-Naini M, Jazayeri SB, Maroufi SF, Ghodsi Z, et al. Epidemiology of Traumatic Spinal Cord Injury in Developing Countries from 2009 to 2020: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2022;56:219–39. https://doi.org/10.1159/000524867 .
doi: 10.1159/000524867 pubmed: 35512643
Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell PC, et al. Interferon-γ Release Assays for Active Pulmonary Tuberculosis Diagnosis in Adults in Low- and Middle-Income Countries: Systematic Review and Meta-analysis. J Infect Dis. 2011;204:S1120.
doi: 10.1093/infdis/jir410 pubmed: 21996694 pmcid: 3192542

Auteurs

Shiama Balendra (S)

UCL-University College London, London, United Kingdom. shiama.balendra@nhs.net.
King's College Global Health Partnership, King's College London, London, United Kingdom. shiama.balendra@nhs.net.
University of Nebraska Medical Center, Omaha, NE, 68198, USA. shiama.balendra@nhs.net.
Sight and Sound, Great Ormond Street Hospital, London, United Kingdom. shiama.balendra@nhs.net.

Lloyd Harrison-Williams (L)

Jui Government Hospital, Freetown, Sierra Leone.

Jalikatu Mustapha (J)

Connaught Hospital, Freetown, Sierra Leone.

Zikan Koroma (Z)

Connaught Hospital, Freetown, Sierra Leone.

Alicious Kamara (A)

Connaught Hospital, Freetown, Sierra Leone.

Bangi Saradugu (B)

Connaught Hospital, Freetown, Sierra Leone.

Osman Conteh (O)

Connaught Hospital, Freetown, Sierra Leone.

Theophilus Kanu (T)

Connaught Hospital, Freetown, Sierra Leone.

Santigie Kamara (S)

Connaught Hospital, Freetown, Sierra Leone.

Sheku Alhaji Koroma (SA)

Connaught Hospital, Freetown, Sierra Leone.

Matthew Vandy (M)

Connaught Hospital, Freetown, Sierra Leone.

Laura Ward (L)

Emory University, Atlanta, GA, USA.

Huachun Wang (H)

University of Nebraska Medical Center, Omaha, NE, 68198, USA.

Tolulope Fashina (T)

University of Nebraska Medical Center, Omaha, NE, 68198, USA.

Jessica Shantha (J)

University of California San Francisco/Proctor Foundation, San Francisco, CA, USA.

Steven Yeh (S)

University of Nebraska Medical Center, Omaha, NE, 68198, USA.

Alasdair Kennedy (A)

King's College Global Health Partnership, King's College London, London, United Kingdom.
Moorfields Eye Hospital NHS Foundation Trust, London, EC1V 9EL, UK.

Classifications MeSH